Anthem Biosciences IPO allotment status declared; what GMP signals as focus shifts on listing date
The bidding for the public issue was open from July 14 to July 16. Anthem Biosciences IPO allotment date was July 17, and Anthem Biosciences IPO listing date is likely July 21.
Anthem Biosciences shares will be listed on both the stock exchanges, BSE and NSE.
'Trading members of the Exchange are hereby informed that the equity shares of Anthem Biosciences Limited shall be listed and admitted to dealings on the Exchange in due course,' a notice on the BSE said.
Ahead of Anthem Biosciences IPO listing, investors watch out for the trends in grey market premium (GMP) to gauge the estimated listing price. Here's what Anthem Biosciences IPO GMP today signals ahead of the listing.
Anthem Biosciences shares are witnessing a bullish trend in the unlisted market with a strong grey market premium (GMP). Anthem Biosciences IPO GMP today is ₹ 144 per share, according to market experts. This indicates that in the grey market, Anthem Biosciences shares are trading higher by ₹ 144 than their issue price.
Anthem Biosciences IPO GMP today signals that the estimated listing price of Anthem Biosciences shares would be ₹ 714 apiece, which is at a premium of more than 25% to the IPO price of ₹ 570 per share.
Anthem Biosciences IPO was open for public subscription from Monday, July 14, to Wednesday, July 16. Anthem Biosciences IPO allotment date was July 17, and the Anthem Biosciences IPO listing date is July 21. Anthem Biosciences shares will be listed on BSE and NSE.
The company raised ₹ 3,395.00 crore from the book-building issue at a fixed IPO price band of ₹ 570 per share. The IPO was entirely an offer-for-sale (OFS) of 5.96 crore equity shares.
Anthem Biosciences IPO was subscribed 63.86 times in total, as per the NSE subscription data. The retail portion was booked 5.64 times, while the Non Institutional Investors (NII) segment was subscribed 42.36 times. The Qualified Institutional Buyers (QIBs) category received 182.65 times subscription.
JM Financial is the book-running lead manager of the Anthem Biosciences IPO, while Kfin Technologies is the registrar for the issue.
Disclaimer: The views and recommendations made above are those of individual analysts or broking companies, and not of Mint. We advise investors to check with certified experts before making any investment decisions.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
News18
6 hours ago
- News18
Tech Mahindra arm Pininfarina raises stake in Signature to 84 pc
New Delhi, Aug 15 (PTI) Pininfarina, a step-down subsidiary of Tech Mahindra, has raised its stake in Signature, an associate company, to 84 per cent from 24 per cent for 1,34,375 euros, according to a statutory filing by the IT services company on Friday. With this transaction, Signature has become a subsidiary of Pininfarina and a step-down subsidiary of the company, Tech Mahindra said in a BSE filing. '…Pininfarina S.p.A., a step-down subsidiary of the company, has on 14th August 2025…informed that it has pursuant to an agreement acquired and subscribed to additional stake in Signature S.r.l, an associate company of Pininfarina, thereby increasing its shareholding in Signature from 24 per cent to 84 per cent of its equity share capital," it added. Signature was incorporated in 2018 as a joint venture with Napkin Forever, and its turnover stood at 2.9 million euros as of December 31, 2024. Signature operates from Italy. 'Pininfarina is an associate company of the Promoter. The Promoter company does not hold any interest in this transaction, except to the extent of their shareholding in Pininfarina," the filing said. The move is a related party transaction on an arm's length basis. Signature mainly operates in the stationery business. The acquisition of Signature is aimed at strengthening the presence of Pininfarina in the consumer channel, while further enhancing the Pininfarina brand. The filing pegged the transaction size at 134,375 euros (on cash consideration), of which 1,875 euros is toward subscription of additional shares in Signature and 1,32,500 euros for acquisition of the additional shares from existing shareholders of Signature. PTI MBI BAL BAL view comments First Published: Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
Time of India
7 hours ago
- Time of India
Agentic AI rises: 86% see higher risks, only 2% meet responsible AI gold standards
Infosys Knowledge Institute (IKI),the research arm of Infosys (NSE, BSE, NYSE: INFY), a global leader in next-generation digital services and consulting, today unveiled critical insights into the state of responsible AI (RAI) implementation across enterprises, particularly with the advent of agentic AI . The report, Responsible Enterprise AI in the Agentic Era, surveyed over 1,500 business executives and interviewed 40 senior decision-makers across Australia, France, Germany, UK, US, and New Zealand. The findings show that while 78% of companies see RAI as a business growth driver, only 2% have adequate RAI controls in place to safeguard against reputational risk and financial loss. The report analyzed the effects of risks from poorly implemented AI, such as privacy violations, ethical violations, bias or discrimination, regulatory non-compliance, inaccurate or harmful predictions, among others. It found that 77% of organizations reported financial loss, and 53% of organizations have suffered reputational impact from such AI related incidents. Key findings include: AI risks are widespread and can be severe 95% of C-suite and director-level executives report AI-related incidents in the past two years.39% characterize the damage experienced from such AI issues as 'severe' or 'extremely severe'.86% of executives aware of agentic AI believe it will introduce new risks and compliance issues. Responsible AI (RAI) capability is patchy and inefficient for most enterprises Only 2% of companies (termed 'RAI leaders') met the full standards set in the Infosys RAI capability benchmark — termed 'RAISE BAR' with 15% (RAI followers) meeting three-quarters of the 'RAI leader' cohort experienced 39% lower financial losses and 18% lower severity from AI do several things better to achieve these results including developing improved AI explainability, proactively evaluating and mitigating against bias, rigorously testing and validating AI initiatives and having a clear incident response plan. Executives view RAI as a growth driver 78% of senior leaders see RAI as aiding their revenue growth and 83% say that future AI regulations would boost, rather than inhibit, the number of future AI on average companies believe they are underinvesting in RAI by 30%. With the scale of enterprise AI adoption far outpacing readiness, companies must urgently shift from treating RAI as a reactive compliance obligation to embracing it proactively as a strategic advantage. To help organizations build scalable, trusted AI systems that fuel growth while mitigating risk, Infosys recommends the following actions: Learn from the leaders: Study the practices of high-maturity RAI organizations who have already faced diverse incident types and developed robust product agility with platform governance: Combine decentralized product innovation with centralized RAI guardrails and RAI guardrails into secure AI platforms: Use platform-based environments that enable AI agents to operate within preapproved data and a proactive RAI office: Create a centralized function to monitor risk, set policy, and scale governance with tools like Infosys' AI3S (Scan, Shield, Steer). Balakrishna D.R., EVP – Global Services Head, AI and Industry Verticals, Infosys said, 'Drawing from our extensive experience working with clients on their AI journeys, we have seen firsthand how delivering more value from enterprise AI use cases, would require enterprises to first establish a responsible foundation built on trust, risk mitigation, data governance, and sustainability. This also means emphasizing ethical, unbiased, safe, and transparent model development. To realize the promise of this technology in the agentic AI future, leaders should strategically focus on platform and product-centric enablement, and proactive vigilance of their data estate. Companies should not discount the important role a centralized RAI office plays as enterprise AI scales, and new regulations come into force.' Jeff Kavanaugh, Head of Infosys Knowledge Institute, Infosys, said, 'Today, enterprises are navigating a complex landscape where AI's promise of growth is accompanied by significant operational and ethical risks. Our research clearly shows that while many are recognizing the importance of Responsible AI, there's a substantial gap in practical implementation. Companies that prioritize robust, embedded RAI safeguards will not only mitigate risks and potentially reduce financial losses but also unlock new revenue streams and thrive as we transition into the transformative agentic AI era.'
Mint
14 hours ago
- Mint
THESE 8 Nifty 500 stocks have doubled investors' money since last Independence Day; do you own any?
The past year has been challenging for Indian stock market investors, as weak earnings, stretched valuations, geopolitical instability, foreign capital outflow, and Trump's tariffs kept the domestic market under pressure. Since last Independence Day, the Nifty 50 has gained just 0.40 per cent, while the broader Nifty 500 index has declined 1.6 per cent over the same period. Stocks, such as Akums Drugs, Tejas Networks, Sterling and Wilson, Vodafone Idea, and Ola Electric have crashed between 50-60 per cent over the last year. However, despite the market downtrend and persistent headwinds, some 200-plus Nifty 500 stocks have delivered gains over the past year. Of these, nearly 150 have surged by at least 10 per cent. Some eight stocks have posted even stellar gains of over 100 per cent, doubling investors' wealth since last Independence Day. let's take a look: BSE stands as the top gainer in the Nifty 500 index, surging about 191 per cent over the last year. The BSE stock hit a 52-week low of ₹ 841.67 on August 14 last year and saw strong gains thereafter, rising to a 52-week high of ₹ 3,030 on June 10. The small-cap stock has surged 171 per cent since last Independence Day, hitting a 52-week high of ₹ 27,740 on April 21 this year. JSW Holdings hit a 52-week low of ₹ 6,455 on August 14 last year. Shares of Godfrey Phillips India have clocked a robust gain of 134 per cent over the last year. This small-cap stock rose to a 52-week high of ₹ 11,444 recently on August 7 after hitting a 52-week low of ₹ 4,112.45 on January 28 this year. Shares of Premier Energies debuted on the NSE and the BSE on September 3 last year. On August 14, 2025, the stock ended at ₹ 986.30. Hence, in less than a year, the stock has surged 119 per cent from its issue price of ₹ 450. The mid-cap stock surged to its record high of ₹ 1,388 on December 17 last year, but declined subsequently on profit booking. Premier Energies hit a record low of ₹ 774.05 on April 7 this year. Paytm has clocked a solid gain of 114 per cent over the last year despite market volatility. It scaled a fresh 52-week high of ₹ 1,187 on August 13 this year after falling to a 52-week low of ₹ 505.50 on August 14 last year. Small-cap stock Authum Investment has gained 108 per cent since last Independence Day. The stock hit a 52-week low of ₹ 1,325.50 on February 28 but rebounded sharply in the subsequent months, rising to a 52-week high of ₹ 2,999 on August 13 this year. With a gain of 104 per cent, JM Financial stands as one of the top gainers in the Nifty 500 index over the last year. It recently hit a 52-week high of ₹ 190 on August 13 after hitting a 52-week low of ₹ 80.20 on April 7 this year. Small-cap pharma stock Laurus Labs has jumped about 101 per cent in the last one year, hitting a 52-week high of ₹ 922.50 on July 30 this year after falling to a 52-week low of ₹ 417.70 on August 14 last year. Read all market-related news here Disclaimer: This story is for educational purposes only. The views and recommendations expressed are those of individual analysts or broking firms, not Mint. We advise investors to consult with certified experts before making any investment decisions, as market conditions can change rapidly and circumstances may vary.
